EMEA anorectic withdrawals
Executive Summary
Celltech and other phentermine manufacturers are considering European Court appeal of the EMEA decision to withdraw the diet drug, but have not done so yet. The company, along with other anorectic drug makers, made a formal appeal to EMEA to prevent withdrawal of the products due to an unfavorable risk/benefit profile, which was rejected (1"The Pink Sheet" April 17, p. 19)
Celltech and other phentermine manufacturers are considering European Court appeal of the EMEA decision to withdraw the diet drug, but have not done so yet. The company, along with other anorectic drug makers, made a formal appeal to EMEA to prevent withdrawal of the products due to an unfavorable risk/benefit profile, which was rejected (1 (Also see "EU Anorectic Market Withdrawal Stalled By Appeal; Phentermine Is Removed" - Pink Sheet, 17 Apr, 2000.)). |